Pasithea Therapeutics announces annual shareholder meeting
KTTA•Items on the voting agenda
Stockholders will vote on the election of two Class III director nominees, including Tiago Reis Marques and Lawrence Steinman.
The meeting agenda also includes ratifying CBIZ CPAs as independent auditor for the fiscal year ending Dec. 31, 2026.
Reverse stock split proposal
Investors will also consider a reverse stock split, with the board authorized to set a ratio from 1-for-2 to 1-for-20.
Annual meeting set for Sept. 9, 2026
Pasithea Therapeutics will hold its annual stockholders meeting in a virtual format on Sept. 9, 2026.
